Statistics for [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling
Total visits
views | |
---|---|
[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling | 218 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
oncotarget-07-23608.pdf | 155 |
java.util.UUID:b3f45f79-cb58-481f-8231-f089c1fc4ede | 48 |
java.util.UUID:297c6146-c563-4ca2-8ae8-c452cbd4ebc6 | 11 |
java.util.UUID:e260a4e1-5fa9-40fe-8bfc-c403bda2c8f4 | 6 |
Top country views
views | |
---|---|
United States | 147 |
Germany | 15 |
China | 6 |
Ukraine | 6 |
Russia | 4 |
Canada | 2 |
Italy | 2 |
United Kingdom | 1 |
Malaysia | 1 |
Portugal | 1 |
Top city views
views | |
---|---|
Wilmington | 46 |
Fairfield | 24 |
Ann Arbor | 20 |
Kiez | 13 |
Houston | 10 |
Cambridge | 9 |
Jacksonville | 7 |
Kiev | 6 |
San Francisco | 4 |
Saint Petersburg | 3 |
Washington | 3 |
Beijing | 2 |
Brooklyn | 2 |
Toronto | 2 |
Grùmolo | 1 |
Gunzenhausen | 1 |
Linda-a-velha | 1 |
Milan | 1 |
Mountain View | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |
Shenzhen | 1 |